Helicobacter pylori seropositivity and stool antigen in patients with hyperemesis gravidarum

Helicobacter pylori seropositivity and stool antigen in patients with

hyperemesis gravidarum

R.S. Karadeniz, M.M. Altay, O. Ozdegirmenci, A. Solaroglu, S. Dilbaz, N.

Hýzel, A. Haberal

Department of Obstetrics and Gynaecology, SSK Maternity and Women’s

Health Hospital, Ankara, Turkey

Objective: To investigate whether Helicobacter pylori is an etiologic

factor in hiperemesis gravidarum.(HG)

Design and Methods: Thirty-one patients with HG and twenty-nine

pregnant controls without HG were included in this prospective study.

Helicobacter pylori serum Immunoglobulin G Antibody (HpIgG Ab) and Helicobacter

pylori stool antigen (HpSA) are investigated which show chronic infection and

active gastrointestinal colonization, respectively. Chi-square and Student

t-test were used accordingly for statistical analysis.

Results: Helicobacter pylori seropositivity was 67.7% in the patients

with HG, and 79.3% in the control group (c2=1.02, p=0.31). HpSA was detected in

22.6% of patients with HG whereas 6.9% of patients in the control group. The

difference was not statistically significant (c2=2.89, p=0.08).

Conclusions: In this study, no relation was found between Helicobacter

pylori and hyperemesis gravidarum. If the clinical index of suspicion from a

helicobacter pylori infection in a pregnant women is high, we recommend that

HpSA detection will be a more reliable diagnostic method since it shows an

active infection rather than a chronic one detected by HpIgG Ab.

Scroll to Top